Cerebral changes in SLE with or without antiphospholipid syndrome. A case-control MRI study

Journal of Neuroimaging

Volumn 18, Issue 1, 2008, Pages 62-65

  Valdés Ferrer, Sergio I ^a   Vega, Felipe ^a   Cantú Brito, Carlos ^a   Ceballos Ceballos, Joel ^a   Estañol, Bruno ^a   García Ramos, Gullermo ^a   Cabral, Antonio R ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Antiphospholipid syndrome; Brain MRI; SLE

Indexed keywords

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BRAIN; BRAIN ATROPHY; BRAIN INFARCTION; BRAIN VENTRICLE DILATATION; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; BRAIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 38049037492     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2007.00183.x     Document Type: Article

References (22)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology Nomenclature and Case definitions for Neuropsychiatric Lupus Syndromes. Arthritis Rheum 1999 42 : 599 608.
2. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharaju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001 57 : 496 500.
3. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus. Prevalence using standard definitions. Neurology 2002 58 : 1214 1220.
4. Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes. Relationship with antiphospholipid antibodies. Neurology 2003 61 : 108 110.
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 40 (9 1725.
6. Alarcón-Segovia D, Pérez-Vázquez ME, Villa AR, Drenkard C, Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992 21 : 275 286.
7. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999 42 : 1309 1311.
8. Guzman J, Cardiel MH, Arce-Salinas A, Sanchez-Guerrero J, Alarcón-Segovia D. Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices. J Rheumatol 1992 19 (10 1551 1558.
9. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997 28 (3 652 659.
10. Rao KCVG. Degenerative diseases and hydrocephalus. In : Cranial MRI and CT Lee SH, Rao KCVG, Zimmerman RA, eds. 4th edition, New York, Mc Graw Hill. 236 237.
11. Alarcón-Segovia D, Estañol B, García-Ramos G, Villa AR. Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus. Ann N Y Acad Sci 1997 823 : 279 288.
12. Jarek MJ, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994 37 : 1609 1613.
13. Hachulla E, Michon-Pasturel U, Leys D, et al. Cerebral magnetic resonance imaging in patients with or without Antiphospholipid antibodies. Lupus 1998 7 : 124 131.
14. Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol 1994 21 : 87 90.
15. Molad Y, Sidi Y, Gornish M, Lerner M, Pinkhas J, Weinberger A. Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions. J Rheumatol 1992 19 (4 556 561.
16. Monastero RMG, Cottini E, Bettini P, et al. Brain abnormalities on magnetic resonance imaging (MRI) and serum levels of autoantibodies in a randomly selected group of systemic lupus erythematosus (SLE) patients. Neurology 1999 Suppl 2 A82. Abstract.
17. Trysberg E, Nylen K, Rosengren LE, Tarkowsky A. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003 48 : 2881 2887.
18. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001 7 : 1189 1193.
19. Lupien SJ, de Leon M, de Santi S, et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998 1 : 69 73.
20. Sapolsky RM, Uno H, Rebert C, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990 10 (9 2897 2902.
21. Chinn RJS, Wilkinson ID, Hall-Craggs MA, et al. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 1997 40 : 36 46.
22. Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 symptomatic volunteers. JAMA 1999 282 : 36 39.